刘新泳山东大学主页平台管理系统--中文主页

论文成果

[1] . Structural and signaling mechanisms of TAAR1 enabled preferential agonist design. Cell, 186, 5347-5362.e24, 2023.
[2] . Target-based drug design strategies to overcome resistance to antiviral agents: opportunities and.... DRUG RESISTANCE UPDATES, 73, 2024.
[3] . Revolutionizing viral disease treatment: Phase separation and lysosome/exosome targeting as new a.... Drug Discov Today., 29, 2024.
[4] . Identification of a small-molecule Tim-3 inhibitor to potentiate T cell-mediated antitumor immuno.... SCIENCE TRANSLATIONAL MEDICINE, 15, 2023.
[5] . SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation.... SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022.
[6] 黄伯世. Structure-Based Design and Discovery of Pyridyl-Bearing Fused Bicyclic HIV-1 Inhibitors: Synthesi.... Journal of Medicianal Chemistry, 64, 13604-13621, 2021.
[7] 黄伯世. First discovery of a potential carbonate prodrug of NNRTI drug candidate RDEA427 with submicromol.... BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 28, 1348, 2018.
[8] 郑义. SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation.... SIGNAL TRANSDUCTION AND TARGETED THERAPY, 7, 2022.
[9] 杨斐. Chiral Metal Nanoparticle Superlattices Enabled by Porphyrin-Based Supramolecular Structures. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2021.
[10] 郑义. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I.... SIGNAL TRANSDUCTION AND TARGETED THERAPY, 5, 2020.

共557条 1/56

首页上页下页尾页页

刘新泳

教授

性别：男

在职信息：在职

所在单位：药学院

入职时间： 1991-07-01

版权所有 ©山东大学　地址：中国山东省济南市山大南路27号　邮编：250100　
查号台：（86）-0531-88395114
值班电话：（86）-0531-88364731　建设维护：山东大学信息化工作办公室　　
访问量：手机版 English 登录山东大学

最后更新时间： ..